These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 21191647)

  • 1. Evidence that L-carnitine and selenium supplementation reduces oxidative stress in phenylketonuric patients.
    Sitta A; Vanzin CS; Biancini GB; Manfredini V; de Oliveira AB; Wayhs CA; Ribas GO; Giugliani L; Schwartz IV; Bohrer D; Garcia SC; Wajner M; Vargas CR
    Cell Mol Neurobiol; 2011 Apr; 31(3):429-36. PubMed ID: 21191647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. L-carnitine blood levels and oxidative stress in treated phenylketonuric patients.
    Sitta A; Barschak AG; Deon M; de Mari JF; Barden AT; Vanzin CS; Biancini GB; Schwartz IV; Wajner M; Vargas CR
    Cell Mol Neurobiol; 2009 Mar; 29(2):211-8. PubMed ID: 18814025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studying the effect of large neutral amino acid supplements on oxidative stress in phenylketonuric patients.
    Kumru B; Ozturk Hismi B; Kaplan DS; Celik H
    J Pediatr Endocrinol Metab; 2019 Mar; 32(3):269-274. PubMed ID: 30835252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effect of L-carnitine on Phenylalanine-induced DNA damage.
    Deon M; Landgraf SS; Lamberty JF; Moura DJ; Saffi J; Wajner M; Vargas CR
    Metab Brain Dis; 2015 Aug; 30(4):925-33. PubMed ID: 25600689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. L-carnitine supplementation as a potential antioxidant therapy for inherited neurometabolic disorders.
    Ribas GS; Vargas CR; Wajner M
    Gene; 2014 Jan; 533(2):469-76. PubMed ID: 24148561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary biomarkers of oxidative stress and plasmatic inflammatory profile in phenylketonuric treated patients.
    Deon M; Sitta A; Faverzani JL; Guerreiro GB; Donida B; Marchetti DP; Mescka CP; Ribas GS; Coitinho AS; Wajner M; Vargas CR
    Int J Dev Neurosci; 2015 Dec; 47(Pt B):259-65. PubMed ID: 26456498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of oxidative stress parameters in treated phenylketonuric patients.
    Sitta A; Barschak AG; Deon M; Terroso T; Pires R; Giugliani R; Dutra-Filho CS; Wajner M; Vargas CR
    Metab Brain Dis; 2006 Dec; 21(4):287-96. PubMed ID: 17146735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. L-carnitine protects DNA oxidative damage induced by phenylalanine and its keto acid derivatives in neural cells: a possible pathomechanism and adjuvant therapy for brain injury in phenylketonuria.
    Faverzani JL; Steinmetz A; Deon M; Marchetti DP; Guerreiro G; Sitta A; de Moura Coelho D; Lopes FF; Nascimento LVM; Steffens L; Henn JG; Ferro MB; Brito VB; Wajner M; Moura DJ; Vargas CR
    Metab Brain Dis; 2021 Oct; 36(7):1957-1968. PubMed ID: 34216350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased peripheral of brain-derived neurotrophic factor levels in phenylketonuric patients treated with l-carnitine.
    Faverzani JL; Guerreiro G; Hammerschmidt TG; Lopes FF; Coelho DM; Sitta A; Mescka CP; Deon M; Wajner M; Vargas CR
    Arch Biochem Biophys; 2023 Nov; 749():109792. PubMed ID: 37863349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative stress in phenylketonuria: future directions.
    Rocha JC; Martins MJ
    J Inherit Metab Dis; 2012 May; 35(3):381-98. PubMed ID: 22116469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of selenium and L-carnitine on oxidative stress in blood of rat induced by 2.45-GHz radiation from wireless devices.
    Gumral N; Naziroglu M; Koyu A; Ongel K; Celik O; Saygin M; Kahriman M; Caliskan S; Kayan M; Gencel O; Flores-Arce MF
    Biol Trace Elem Res; 2009 Dec; 132(1-3):153-63. PubMed ID: 19396408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antioxidant, antiapoptotic, antigenotoxic, and hepatic ameliorative effects of L-carnitine and selenium on cadmium-induced hepatotoxicity and alterations in liver cell structure in male mice.
    Abu-El-Zahab HSH; Hamza RZ; Montaser MM; El-Mahdi MM; Al-Harthi WA
    Ecotoxicol Environ Saf; 2019 May; 173():419-428. PubMed ID: 30798185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence that DNA damage is associated to phenylalanine blood levels in leukocytes from phenylketonuric patients.
    Sitta A; Manfredini V; Biasi L; Treméa R; Schwartz IV; Wajner M; Vargas CR
    Mutat Res; 2009; 679(1-2):13-6. PubMed ID: 19665577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased cytokine levels induced by high phenylalanine concentrations in late diagnosis PKU patients compared to early diagnosis: Anti-inflammatory effect of L-carnitine.
    Faverzani JL; Hammerschmidt TG; Mescka CP; Guerreiro G; Lopes FF; Delgado CA; de Moura Coelho D; Sitta A; Deon M; Wajner M; Vargas CR
    Cell Biochem Funct; 2023 Jun; 41(4):490-500. PubMed ID: 37170672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidative stress in patients with phenylketonuria.
    Sirtori LR; Dutra-Filho CS; Fitarelli D; Sitta A; Haeser A; Barschak AG; Wajner M; Coelho DM; Llesuy S; Belló-Klein A; Giugliani R; Deon M; Vargas CR
    Biochim Biophys Acta; 2005 Apr; 1740(1):68-73. PubMed ID: 15878743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antioxidant and thyroid hormone status in selenium-deficient phenylketonuric and hyperphenylalaninemic patients.
    van Bakel MM; Printzen G; Wermuth B; Wiesmann UN
    Am J Clin Nutr; 2000 Oct; 72(4):976-81. PubMed ID: 11010940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidative stress parameters in urine from patients with disorders of propionate metabolism: a beneficial effect of L:-carnitine supplementation.
    Ribas GS; Biancini GB; Mescka C; Wayhs CY; Sitta A; Wajner M; Vargas CR
    Cell Mol Neurobiol; 2012 Jan; 32(1):77-82. PubMed ID: 21833551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carnitine status in early-treated children, adolescents and young adults with phenylketonuria on low phenylalanine diets.
    Weigel C; Kiener C; Meier N; Schmid P; Rauh M; Rascher W; Knerr I
    Ann Nutr Metab; 2008; 53(2):91-5. PubMed ID: 18946205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antioxidant treatment strategies for hyperphenylalaninemia.
    Mazzola PN; Karikas GA; Schulpis KH; Dutra-Filho CS
    Metab Brain Dis; 2013 Dec; 28(4):541-50. PubMed ID: 23657560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of short- and long-term exposition to high phenylalanine blood levels on oxidative damage in phenylketonuric patients.
    Sitta A; Barschak AG; Deon M; Barden AT; Biancini GB; Vargas PR; de Souza CF; Netto C; Wajner M; Vargas CR
    Int J Dev Neurosci; 2009 May; 27(3):243-7. PubMed ID: 19429389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.